Federation des caisses Desjardins du Quebec’s PDL BioPharma, Inc. PDLI Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-850	Closed	-$2.46K	–	2174
2018 Q4	$2.46K	Hold	850	–	–	﹤0.01%	1895
2018 Q3	$2.24K	Hold	850	–	–	﹤0.01%	1986
2018 Q2	$1.99K	Sell	850 -13,868	-94%	-$38.7K	﹤0.01%	2011
2018 Q1	$43.3K	Hold	14,718	–	–	﹤0.01%	1371
2017 Q4	$40.2K	Hold	14,718	–	–	﹤0.01%	1393
2017 Q3	$50K	Hold	14,718	–	–	﹤0.01%	1313
2017 Q2	$36.4K	Sell	14,718 -176,862	-92%	-$407K	﹤0.01%	1437
2017 Q1	$435K	Buy	+191,580	New	+$424K	0.01%	713

Other funds holding PDLI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's PDLI Position: Q1 2019 in Review

Federation des caisses Desjardins du Quebec sold out of PDL BioPharma, Inc. (PDLI) in Q1 2019, closing a stake of 850 shares — an estimated $2.46K sold.

Federation des caisses Desjardins du Quebec first reported a position in PDLI in Q1 2017 and held it in 8 quarters. The position peaked at $435K in Q1 2017. 157 funds tracked by Wall St. Rank hold PDLI as of Q1 2019.

Federation des caisses Desjardins du Quebec reported no remaining PDL BioPharma, Inc. position as of Q1 2019 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 850 PDL BioPharma, Inc. shares in Q1 2019, an estimated $2.46K.
Federation des caisses Desjardins du Quebec first reported a position in PDL BioPharma, Inc. in Q1 2017 and held it in 8 quarters.
Federation des caisses Desjardins du Quebec's PDL BioPharma, Inc. position peaked at $435K in Q1 2017.
157 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2019.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2019, filed 30 Aug 2024.